(Q23920590)

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

2 references

2 February 2024

inferred from email address

cites work

Diabetes and cancer: a consensus report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Quantifying heterogeneity in a meta-analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Meta-analysis in clinical trials

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

19 March 2017

https://api.crossref.org/works/10.1155%2F2014%2F189384

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

The file drawer problem and tolerance for null results

19 March 2017

1 reference

https://api.crossref.org/works/10.1155/2014/189384

Banting lecture 1988. Role of insulin resistance in human disease

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

The metabolic syndrome--a new worldwide definition

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

The role of adiponectin signaling in metabolic syndrome and cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome and risk of cancer: a systematic review and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Diabetes and breast cancer risk: a meta-analysis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Insulin resistance in relation to melanoma risk.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Surface anthropometric indices in obesity-related metabolic diseases and cancers.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Role of cholesterol in the development and progression of breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Molecular mechanisms of leptin and adiponectin in breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolism in cancer patients.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Accuracy of body mass index to determine obesity in women with breast cancer: an observational study of Taiwanese sample

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

The association of metabolic syndrome with triple-negative breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Insulin, insulin-like growth factors and neoplasia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Insulin resistance, obesity and breast cancer risk

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome pandemic.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Diabetes mellitus and risk of breast cancer: a meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Review article: steatosis, the metabolic syndrome and cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Breast cancer risk in the WHI study: the problem of obesity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Obesity, adipocytokines, and insulin resistance in breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Leptin is a growth factor in cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Central obesity and breast cancer risk: a systematic review.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Breast cancer and obesity: an update

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Risk of endometrial and breast cancer in patients with diabetes mellitus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Timing of weight gain in relation to breast cancer risk

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Sex hormone-binding globulin and insulin resistance in African-American women.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Dual effects of weight and weight gain on breast cancer risk

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

A meta-analysis of body mass index and risk of premenopausal breast cancer

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic syndrome and incidence of liver and breast cancers in Japan.

30 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Hypertension, diuretics and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Fasting serum glucose level and cancer risk in Korean men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Plasma lipid alterations in African-American women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Metabolic syndrome and cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Anthropometry and breast cancer risk in Nigerian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Metabolic syndrome as a prognostic factor for breast cancer recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Leptin Levels in Type 2 Diabetes: Associations with Measures of Insulin Resistance and Insulin Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Visceral obesity, metabolic syndrome, insulin resistance and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Metabolic syndrome and the risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Hypertension and Hormone-Related Neoplasms in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Liposoluble vitamins and lipid parameters in breast cancer. A joint study in northern Italy and southern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295135

Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer

29 November 2018

1 reference

12 December 2020

Metabolic syndrome is an independent risk factor for breast cancer

1 reference

12 December 2020

Relation between obesity and breast cancer in young women

1 reference

12 December 2020

Prevalence of the metabolic syndrome in relation to self-reported cancer history

1 reference

12 December 2020

Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay

1 reference

12 December 2020

Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?

1 reference

12 December 2020

Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer

1 reference

12 December 2020

Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?

1 reference

12 December 2020

Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin

1 reference

12 December 2020

Serum lipids and lipoprotein disorders in cancer patients

1 reference

12 December 2020

A prospective study in general practice on breast-cancer risk in postmenopausal women

1 reference

12 December 2020

Adipose tissue leptin production and plasma leptin kinetics in humans

1 reference

12 December 2020

Metabolic syndrome and breast cancer risk

1 reference

12 December 2020

Research Techniques in the Study of Human Beings

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F189384

7 January 2021